论文部分内容阅读
药品问题,与每个人息息相关,备受社会关注,自然也吸引着代表们的目光。促进医药产业健康发展,历来是全国两会的热点话题。今年,全国人大代表王玉芝就带来了两份与医药产业密切相关的建议。第一份建议,是关于保证药品注册文号审评审批时限的。王玉芝代表认为,近年来,药品审评审批进展比较缓慢,已经制约我国医药事业发展。王玉芝说,2007年,国家有关部门组织药监系统对申报过多、过滥的药品注册申请严格审核,有近万个不符合规定的药品申请
The issue of medicine, which is closely linked to everyone and attracts the attention of the community, naturally attracts the deputies. Promoting the healthy development of the pharmaceutical industry has always been a hot topic in the NPC and CPPCC sessions. This year, Wang Yuzhi, NPC deputy, brought two proposals closely related to the pharmaceutical industry. The first proposal is about the drug registration number to review the approval deadline. Wang Yuzhi representatives believe that in recent years, the review and approval of drug review progress is relatively slow, has restricted the development of China’s pharmaceutical industry. Wang Yuzhi said that in 2007, the relevant departments of the state organized the drug control system to strictly examine the applications for registration of excessive and excessive drugs, and nearly 10,000 applications for drugs that did not meet the requirements